Atlantic Labs

What they fund

• Geographic Focus — The firm primarily targets companies operating within Europe, leveraging its regional expertise to identify and support high-potential ventures in the European market [Profile].
• Sector Focus — Atlantic Labs invests in technology that pushes "beyond the edge of the known," with specific thematic interests in the food industry, industrial era technologies, and experiences [Profile].
• Stage & Check Size — The fund deploys capital in checks ranging from €25,000 to €5,000,000, allowing for flexibility in both early-stage support and larger growth rounds [Profile].
• Portfolio Size — As of the latest data, the firm has a portfolio count of 1 company, indicating a highly concentrated or early-stage investment strategy [Profile].

Investment thesis

Atlantic Labs backs founders building technology beyond the edge of the known, focusing on non-normal ideas that transform the impossible into the possible [1]. The firm prioritizes breakthrough technologies over incremental improvements, applying this thesis to three key verticals: the food industry, industrial era technologies, and experiences [1].

Value add

• Hands-on Support — The firm provides direct, hands-on support to its portfolio companies, engaging actively in their operational and strategic development [Profile].
• Strategic Guidance — Atlantic Labs offers strategic guidance to help founders navigate complex challenges and scale their businesses effectively [Profile].
• Network Access — The firm leverages its network to connect portfolio companies with potential partners, customers, and other resources necessary for growth [Profile].

Portfolio focus

technology beyond the edge of the known, food industry, industrial era, experiences

Notable investments & exits

• Rows — Rows is listed as a notable exit for Atlantic Labs, representing a successful departure from the firm's portfolio [Profile].
• Bunch — Bunch is identified as a notable exit, indicating a prior successful investment outcome for the firm [Profile].
• Apryl — Apryl is cited as a notable exit, further demonstrating the firm's track record in identifying and supporting companies that achieve significant milestones [Profile].
• Layzr — Layzr is listed as a notable exit, completing the set of known successful departures from Atlantic Labs' portfolio [Profile].

Strategic implications

Atlantic Labs operates as a thematic, conviction-driven fund rather than a traditional stage-specific VC, which allows it to bypass early-stage competition but requires significant founder education. The 2025 founding date suggests a fresh mandate with no legacy portfolio drag, enabling a clean slate strategy focused entirely on 'non-normal' ideas. The primary risk lies in the execution of a highly unconventional thesis; without a clear track record or established co-investment network, the firm may struggle to attract follow-on capital for its portfolio companies.

Where they could go further

Atlantic Labs should establish a clear co-investment strategy or syndicate partners early on to share the risk of backing 'non-normal' ideas and to validate the thesis for external LPs. The firm needs to define specific milestones for its 'food, industrial, and experiences' verticals to avoid being too broad, perhaps by focusing on a sub-segment like industrial automation or sustainable food tech. Building a founder community or accelerator-like structure could help Atlantic Labs source and support founders who are developing 'beyond the edge' technologies, which are often highly technical and require hands-on support.